thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » Granules Clears FDA Pre-Inspection Audit For 3 Products

Business

Granules Clears FDA Pre-Inspection Audit For 3 Products

TheNewsFacts
Last updated: July 21, 2021 6:22 pm
TheNewsFacts
Share
Granules Clears FDA Pre-Inspection Audit for 3 Products
SHARE

Granules India announced today that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA had undergone a Pre-Approval Inspection (PAI) audit by the U.S. Food and Drug Administration (FDA) from 21st June 2021 to 25th June 2021.

The audit is a pre-approval inspection for three of its applications filed from this facility. The FDA issued two minor observations during the audit.

Granules Clears FDA Pre-Inspection audit for its 3 applications

“The observations were responded to within the stipulated time, and we are happy to inform that the FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021. This is the fifth US FDA audit for this facility” said Ms. Priyanka Chigurupati, Executive Director, GPI.

The audit was triggered following Granules US subsidiary filing three abbreviated new drug applications from this facility.

The USFDA issued two minor observations during the audit, and the company had responded within the stipulated time.

This facility was inspected by the US FDA from 21st to 25th June 2021. The audit is a pre-approval inspection for three products filed from this facility. “We will be responding to the two observations within the stipulated time period,” Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc in a statement earlier said.

GPI is a US FDA & DEA approved facility which spreads over 100,000 sq ft area, with established R&D & Manufacturing capabilities for low volume, oral solid dosage forms.

The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) which gives the customers flexibility and choice. Granules support customers with unique value, extensive product range and proactive solutions.

Granules India along with its subsidiaries has a global presence which extends to over 250 customers in over 75 countries through its offices in India, U.S. & U.K. and has seven manufacturing facilities out of which six are located in India and one in the USA. Five out of these seven have regulatory approvals from the USFDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC and HALAL.

TAGGED: Granules Clears FDA Audit, Granules Clears FDA Pre Inspection Audit, Granules India
Share This Article
Twitter Email Copy Link Print
Previous Article Raj Kundra Arrest: Shilpa Shetty is not shocked !!! Raj Kundra Arrest: Shilpa Shetty is not shocked !!!
Next Article Pandemic:15 lakh children lost their loved ones - The Lancet Pandemic:15 lakh children lost their loved ones – The Lancet

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

The Real Story Behind Alec Baldwin Fatal Shot: Latest Report

According to the latest reports in media about Alec Baldwin prop gun shooting incident which…

By TheNewsFacts

Dainik Jagran Faces Backlash Over Virat Kohli- Rohit Sharma Comparison

In the wake of a controversial article published by Dainik Jagran, a leading Indian Hindi…

By TheNewsFacts

Sam Curran becomes most expensive player ever in IPL Auction History

Sam Curran, wrote his name in the record books by becoming the most expensive player…

By TheNewsFacts

You Might Also Like

Meenakshi Alternates
BusinessLatest News

Meenakshi Group Unveils Rs. 700Cr “Meenakshi Real Assets Fund”

By NewsFacts Bureau
AM Green
Business

AM Green, Port of Rotterdam To Enable 1 MTPA , $1B Trade for Green Fuels

By TheNewsFacts
Rio Tinto
Business

AMG, Rio Tinto Plan 500K TPA Green Aluminium in India

By TheNewsFacts
BluSmart
Business

BluSmart’s EV U-Turn: Platform Out, Fleet In

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?